Shareholders to Vote on Reverse Stock Split (Up to 1:30) and Blank Check Preferred Stock Amid Delisting Threat
summarizeSummary
My Size, Inc. will hold an annual meeting to vote on a reverse stock split (up to 1:30) to regain Nasdaq compliance and to authorize 10 million shares of blank check preferred stock, enabling future dilutive financing.
check_boxKey Events
-
Proposed Reverse Stock Split
Shareholders will vote on granting the board discretionary authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-30. This is primarily to regain compliance with Nasdaq's minimum $1.00 bid price requirement, following a delisting notice received on March 2, 2026.
-
Authorization of Blank Check Preferred Stock
The company is seeking approval to amend its charter to authorize 10,000,000 shares of preferred stock. The board would have sole discretion to determine the terms, including voting rights, conversion features, and liquidation preferences, without further shareholder approval, which could lead to significant future dilution.
-
Critical Nasdaq Compliance Deadline
The reverse stock split is a direct response to a Nasdaq delisting notice, with a compliance deadline of August 31, 2026. The company's stock is currently trading near its 52-week low.
-
Ongoing Financial Distress
These proposals follow recent filings (April 15, 2026 10-K and May 14, 2026 10-Q) that disclosed a 'going concern' warning, increased net losses, and a critical cash shortage, underscoring the urgent need for capital and compliance measures.
auto_awesomeAnalysis
My Size, Inc. is seeking shareholder approval for two critical proposals: a reverse stock split of up to 1-for-30 and the authorization of 10 million shares of blank check preferred stock. The reverse split is a direct response to a Nasdaq delisting notice for failing to maintain the minimum $1.00 bid price, a compliance deadline the company faces by August 31, 2026. The authorization of blank check preferred stock provides the board with broad authority to issue new shares with potentially superior rights, which could be highly dilutive to existing common shareholders, especially given the company's ongoing 'going concern' warning and critical cash shortage. These actions are crucial for the company's continued listing and future financing capabilities, but carry significant risks of further dilution.
At the time of this filing, MYSZ was trading at $0.49 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.48 to $1.65. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.